PT  - JOURNAL ARTICLE
AU  - Colleen C. Naughton
AU  - Fernando A. Roman, Jr.
AU  - Ana Grace F. Alvarado
AU  - Arianna Q. Tariqi
AU  - Matthew A. Deeming
AU  - Kyle Bibby
AU  - Aaron Bivins
AU  - Joan B. Rose
AU  - Gertjan Medema
AU  - Warish Ahmed
AU  - Panagis Katsivelis
AU  - Vajra Allan
AU  - Ryan Sinclair
AU  - Yihan Zhang
AU  - Maureen N. Kinyua
TI  - Show us the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps
AID  - 10.1101/2021.03.14.21253564
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.14.21253564
4099  - http://medrxiv.org/content/early/2021/03/17/2021.03.14.21253564.short
4100  - http://medrxiv.org/content/early/2021/03/17/2021.03.14.21253564.full
AB  - A year since the declaration of the global coronavirus disease 2019 (COVID-19) pandemic there have been over 110 million cases and 2.5 million deaths. Using methods to track community spread of other viruses such as poliovirus, environmental virologists and those in the wastewater based epidemiology (WBE) field quickly adapted their existing methods to detect SARS-CoV-2 RNA in wastewater. Unlike COVID-19 case and mortality data, there was not a global dashboard to track wastewater monitoring of SARS-CoV-2 RNA worldwide. This study describes the development of the “COVIDPoops19” dashboard to disseminate information regarding sites, universities, research institutions and private laboratories in countries that are involved in WBE for SARS-CoV-2. Methods to assemble the dashboard combined standard literature review, direct submissions, and daily, social media keyword searches. Over 200 universities, 1,000 sites, and 50 countries with 59 dashboards monitor wastewater for SARS-CoV-2 RNA. However, monitoring is inequitably distributed in high-income countries and data are not widely shared publicly or accessible to researchers to inform public health actions, meta-analysis, better coordinate, and determine equitable distribution of monitoring sites. For WBE to be used to its full potential during COVID-19 and beyond, show us the data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding sources include: a Center for Information Technology Research in the Interest of Society (CITRIS) COVID-19 emergency seed grant, Bill and Melinda Gates Foundation, and National Science Foundation (NSF) #2027752 and #2038087. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or other funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UC Merced IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available publicly through ArcGIS online. A link to our public dashboard is here: https://arcg.is/1aummW https://arcg.is/1aummW